Anika Therapeutics Inc.

NASDAQ:ANIK   10:06:48 AM EDT
25.62
-0.28 (-1.10%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)375.03M
Current PEN/A
Forward PE 91.5
2yr Forward PE 29.79
See more stats
Estimates Current Quarter
Revenue$39.14 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$25.70
50-Day MA$25.40
200-Day MA$22.11
See more pivots

Anika Therapeutics Inc. Stock, NASDAQ:ANIK

32 Wiggins Avenue, Bedford, Massachusetts 01730
United States of America
Phone: +1.781.457.9000
Number of Employees: 357

Description

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.